Treating Preeclampsia in the COVID-19 Era: Is Allopurinol Useful as an Adjuvant Therapy? A Case Report and Review of the Literature

Acute respiratory syndrome-related coronavirus 2, or SARS-CoV-2, mainly affects the vulnerable population, especially those with comorbidities, such as pregnant women. SARS-CoV-2 has been found to cause multiple manifestations, one of which is preeclampsia. In preeclampsia, uric acid is excessively...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Melinda-Ildiko Mitranovici, Diana Maria Chiorean, Maria Cezara Mureșan, Corneliu-Florin Buicu, Raluca Moraru, Liviu Moraru, Titiana Cornelia Cotoi, Ovidiu Simion Cotoi, Havva Serap Toru, Adrian Apostol, Sabin Gligore Turdean, Ion Petre, Claudiu Mărginean, Ioan Emilian Oală, Viviana Ivan, Lucian Pușcașiu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2023-01-01
Edice:	Stresses
Témata:	allopurinol preeclampsia SARS-CoV-2 infection
On-line přístup:	https://www.mdpi.com/2673-7140/3/1/10
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!